Kailos Genetics' Unattributed VC Round

Kailos Genetics raised a round of funding on July 11, 2017. Investors include In-Q-Tel.

Kailos Genetics helps predict individual patient response to drugs, enabling healthcare providers to identify responders and non-responders to potential drug therapy, avoid adverse drug reactions, and…

Articles about Kailos Genetics' Unattributed VC Round: